HighCape is committed to a focused and specialized portfolio, which allows us to work closely with the management teams at each company to maximize their potential.
Date initial fund closed:
Number of planned investements:
Stage of growth for targeted investments:
Cheetah Medical was founded in 2001 with the mission of helping clinicians better manage their patient’s fluid status. Since then, Cheetah Medical has become a leader in non-invasive Cardiac Output and Hemodynamic monitoring with its proprietary CE-marked and FDA-cleared CHEETAH NICOM™ system.
Cheetah Medical is based in Newton, Massachusetts, with offices in Tel-Aviv, Israel and Portland, Oregon.
TELA Bio is a surgical reconstruction company committed to collaborating with surgeons to understand and address the unmet clinical needs in soft tissue repair. The Company’s first innovation is a novel product portfolio of Reinforced BioScaffolds, [CE-marked and FDA-cleared] for use in hernia repair and abdominal wall reconstruction.
TELA Bio is based in Malvern, Pennsylvania.
Aziyo Biologics, Inc. was formed by HighCape Partners and Tissue Banks International in 2015. The company’s mission is to impact healthcare through the innovation of new regenerative medicine products. Specifically, Aziyo partners with its clients to develop and deliver customized tissue products for use in orthopedic, spinal, sports medicine and dermal applications. For more information please visit aziyobio.com.
Aziyo Biologics is based in Richmond, CA.
ZipLine Medical is an innovator in cost-effective, non-invasive surgical skin closure devices that deliver high patient satisfaction and surgeon efficiency. Zip Surgical Skin Closure devices have been used in more than 100,000 cases and in over 30 countries worldwide.
ZipLine Medical was founded by Amir Belson, M.D. and is headquartered in Campbell, CA.